Analytical Data
-
基因名
pac
- Application
-
别名
pac；PAC1；Dual specificity Protein phosphatase 2
-
种属
E.coli
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P13249
-
表达区间
1-199aa
-
氨基酸序列
MTEYKPTVRLATRDDVPRAVRTLAAAFADYPATRHTVDPDRHIERVTELQELFLTRVGLDIGKVWVADDGAAVAVWTTPESVEAGAVFAEIGPRMAELSGSRLAAQQQMEGLLAPHRPKEPAWFLATVGVSPDHQGKGLGSAVVLPGVEAAERAGVPAFLETSAPRNLPFYERLGFTVTADVEVPEGPRTWCMTRKPGA
-
分子量
37.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Pac (Protein Antigenic Complex) recombinant proteins have gained significant attention in the field of molecular biology and immunology due to their potential applications in vaccine development and disease diagnostics. The need for effective vaccines and accurate diagnostic tools has driven researchers to explore various recombinant protein technologies. Pac proteins are particularly fascinating because they can enhance the immunogenicity of antigens, thereby improving the immune response. Additionally, the ability to produce these proteins in a controlled environment allows for the generation of consistent and high-purity materials, which are crucial for clinical applications. Previous studies have shown that the incorporation of adjuvants or the use of specific delivery systems in conjunction with Pac proteins can further boost their efficacy. As infectious diseases and emerging pathogens continue to pose global health challenges, the investigation of Pac recombinant proteins offers promising avenues for developing novel therapeutics and preventive measures. The ongoing research aims to understand the mechanisms of action, optimize production methods, and evaluate the safety and efficacy of these proteins in preclinical and clinical settings, reflecting a significant step forward in the quest for innovative solutions in public health.
